id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0362-0003,FDA,FDA-2011-N-0362,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals",Notice,General Notice,2011-09-28T04:00:00Z,2011,9,,,2012-03-24T19:36:34Z,2011-24991,0,0,0900006480f4014b
FDA-2011-N-0362-0001,FDA,FDA-2011-N-0362,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals",Notice,N-Notice,2011-05-31T04:00:00Z,2011,5,2011-05-31T04:00:00Z,2011-08-02T03:59:59Z,2011-05-31T15:13:06Z,2011-13441,0,0,0900006480e353a1